The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding

Molecular and Cellular Biology

Volumn 25, Issue 8, 2005, Pages 3247-3260

  Gridasova, Anastasia A ^a   Henry, R William ^a  

^a Michigan State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA DIRECTED RNA POLYMERASE III; PROTEIN P53; RECOMBINANT PROTEIN; RNA POLYMERASE II; SMALL NUCLEAR RNA; TATA BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CONTROLLED STUDY; DNA BINDING; FEMALE; GENE ACTIVATION; GENE REPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN LOCALIZATION; ULTRAVIOLET RADIATION;

CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMANS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RESPONSE ELEMENTS; RNA POLYMERASE II; RNA POLYMERASE III; RNA, SMALL NUCLEAR; TATA-BOX BINDING PROTEIN; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 16244367142     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.8.3247-3260.2005     Document Type: Article

References (72)

1. Bailey, A. D., Z. Li, T. Pavelitz, and A. M. Weiner. 1995. Adenovirus type 12-induced fragility of the human RNU2 locus requires U2 small nuclear RNA transcriptional regulatory elements. Mol. Cell. Biol. 15:6246-6255.
2. Barlev, N. A., L. Liu, N. H. Chehab, K. Mansfield, K. G. Harris, T. D. Halazonetis, and S. L. Berger. 2001. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell 8:1243-1254.
3. Budde, A., and I. Grummt. 1999. p53 represses ribosomal gene transcription. Oncogene 18:1119-1124.
4. Cain, C., S. Miller, J. Ahn, and C. Prives. 2000. The N terminus of p53 regulates its dissociation from DNA. J. Biol. Chem. 275:39944-39953.
5. Cairns, C. A., and R. J. White. 1998. p53 is a general repressor of RNA polymerase III transcription. EMBO J. 17:3112-3123.
6. Carey, M., and S. T. Smale. 2000. Transcriptional regulation in eukaryotes. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
7. Chen, X., G. Farmer, H. Zhu, R. Prywes, and C. Prives. 1993. Cooperative DNA binding of p53 with TFIID (TBP): a possible mechanism for transcriptional activation. Genes Dev. 7:1837-1849. [Erratum, 7:2652.]
8. Chen, X., L. J. Ko, L. Jayaraman, and C. Prives. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:2438-2451.
9. Chesnokov, I., W. M. Chu, M. R. Botchan, and C. W. Schmid. 1996. p53 inhibits RNA polymerase III-directed transcription in a promoter- dependent manner. Mol. Cell. Biol. 16:7084-7088.
10. Crighton, D., A. Woiwode, C. Zhang, N. Mandavia, J. P. Morton, L. J. Warnock, J. Milner, R. J. White, and D. L. Johnson. 2003. p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J. 22:2810-2820.
11. Eichhorn, K., and S. P. Jackson. 2001. A role for TAF3B2 in the repression of human RNA polymerase III transcription in nonproliferating cells. J. Biol. Chem. 276:21158-21165.
12. el-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1:45-49.
13. Eliceiri, G. L. 1974. Short-lived, small RNAs in the cytoplasm of HeLa cells. Cell 3:11-14.
14. Eliceiri, G. L., and J. H. Smith. 1983. Sensitivity to UV radiation of small nuclear RNA synthesis in mammalian cells. Mol. Cell. Biol. 3:2151-2155.
15. Espinosa, J. M., and B. M. Emerson. 2001. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell 8:57-69.
16. Farmer, G., J. Colgan, Y. Nakatani, J. L. Manley, and C. Prives. 1996. Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo. Mol. Cell. Biol. 16:4295-4304.
17. Frederiksen, S., I. R. Pedersen, P. Hellung-Larsen, and J. Engberg. 1974. Metabolic studies of small molecular weight nuclear RNA components in BHK-21 cells. Biochim. Biophys. Acta 340:64-76.
18. Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606.
19. Henry, R. W., E. Ford, R. Mital, V. Mittal, and N. Hernandez. 1998. Crossing the line between RNA polymerases: transcription of human snRNA genes by RNA polymerases II and III. Cold Spring Harbor Symp. Quant. Biol. 63: 111-120.
20. Henry, R. W., B. Ma, C. L. Sadowski, R. Kobayashi, and N. Hernandez. 1996. Cloning and characterization of SNAP50, a subunit of the snRNA-activating protein complex SNAPc. EMBO J. 15:7129-7136.
21. Henry, R. W., V. Mittal, B. Ma, R. Kobayashi, and N. Hernandez. 1998. SNAP19 mediates the assembly of a functional core promoter complex (SNAPc) shared by RNA polymerases II and III. Genes Dev. 12:2664-2672.
22. Henry, R. W., C. L. Sadowski, R. Kobayashi, and N. Hernandez. 1995. A TBP-TAF complex required for transcription of human snRNA genes by RNA polymerase II and III. Nature 374:653-656.
23. Hernandez, N. 2001. Small nuclear RNA genes: a model system to study fundamental mechanisms of transcription. J. Biol. Chem. 276:26733-26736.
24. Hernandez, N. 1992. Transcription of vertebrate snRNA genes and related genes, p. 281-313. In S. McKnight and K. Yamamoto (ed.), Transcriptional regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
25. Hirsch, H. A., G. W. Jawdekar, K. A. Lee, L. Gu, and R. W. Henry. 2004. Distinct mechanisms for repression of RNA polymerase III transcription by the retinoblastoma tumor suppressor protein. Mol. Cell. Biol. 24:5989-5999.
26. Ho, J., and S. Benchimol. 2003. Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ, 10:404-408.
27. Jacobs, E. Y., I. Ogiwara, and A. M. Weiner. 2004. Role of the C-terminal domain of RNA polymerase II in U2 snRNA transcription and 3′ processing. Mol. Cell. Biol. 24:846-855.
28. Jin, S., and A. J. Levine. 2001. The p53 functional circuit. J. Cell Sci. 114:4139-4140.
29. Johnson, R. A., T. A. Ince, and K. W. Scotto. 2001. Transcriptional repression by p53 through direct binding to a novel DNA element. J. Biol. Chem. 276:27716-27720.
30. Kaeser, M. D., and R. D. Iggo. 2002. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc. Natl. Acad. Sci. USA 99:95-100.
31. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054-1072.
32. Kuhlman, T. C., H. Cho, D. Reinberg, and N. Hernandez. 1999. The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter. Mol. Cell. Biol. 19:2130-2141.
33. Kunkel, G. R., and J. D. Hixson. 1998. The distal elements, OCT and SPH, stimulate the formation of preinitiation complexes on a human U6 snRNA gene promoter in vitro. Nucleic Acids Res. 26:1536-1543.
34. Lee, S. K., S. L. Yu, L. Prakash, and S. Prakash. 2001. Requirement for yeast RAD26, a homolog of the human CSB gene, in elongation by RNA polymerase II. Mol. Cell. Biol. 21:8651-8656.
35. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
36. Li, Y. P., R. Tomanin, J. R. Smiley, and S. Bacchetti. 1993. Generation of a new adenovirus type 12-inducible fragile site by insertion of an artificial U2 locus in the human genome. Mol. Cell. Biol. 13:6064-6070.
37. Li, Z., A. D. Bailey, J. Buchowski, and A. M. Weiner. 1998. A tandem array of minimal U1 small nuclear RNA genes is sufficient to generate a new adenovirus type 12-inducible chromosome fragile site. J. Virol. 72:4205-4211.
38. Li, Z., A. Yu, and A. M. Weiner. 1998. Adenovirus type 12-induced fragility of the human RNU2 locus requires p53 function. J. Virol. 72:4183-4191.
39. Liao, D., A. Yu, and A. M. Weiner. 1999. Coexpression of the adenovirus 12 E1B 55 kDa oncoprotein and cellular tumor suppressor p53 is sufficient to induce metaphase fragility of the human RNU2 locus. Virology 254:11-23.
40. Liu, L., D. M. Scolnick, R. C. Trievel, H. B. Zhang, R. Marmorstein, T. D. Halazonetis, and S. L. Berger. 1999. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19:1202-1209.
41. Liu, X., C. W. Miller, P. H. Koeffler, and A. J. Berk. 1993. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell. Biol. 13:3291-3300.
42. Lobo, S. M., and N. T. Hernandez. 1994. Transcription of snRNA genes by RNA polymerases II and III, p. 127-159. In R. C. Conaway and J. W. Conaway (ed.), Transcription: mechanisms and regulation. Raven Press, Ltd., New York, N.Y.
43. Lobo, S. M., M. Tanaka, M. L. Sullivan, and N. Hernandez. 1992. A TBP complex essential for transcription from TATA-less but not TATA-containing RNA polymerase ill promoters is part of the TFIIIB fraction. Cell 71:1029-1040.
44. Luo, J., M. Li, Y. Tang, M. Laszkowska, R. G. Roeder, and W. Gu. 2004. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl. Acad. Sci. USA 101:2259-2264.
45. McCulloch, V., P. Hardin, W. Peng, J. M. Ruppert, and S. M. Lobo-Ruppert. 2000. Alternatively spliced hBRF variants function at different RNA polymerase III promoters. EMBO J. 19:4134-4143.
46. McKay, B. C., F. Chen, S. T. Clarke, H. E. Wiggin, L. M. Harley, and M. Ljungman. 2001. UV light-induced degradation of RNA polymerase II is dependent on the Cockayne's syndrome A and B proteins but not p53 or MLH1. Mutat. Res. 485:93-105.
47. Morra, D. S., B. P. Eliceiri, and G. L. Eliceiri. 1986. Effect of UV light on small nuclear RNA synthesis: increased inhibition during postirradiation cell incubation. Mol. Cell. Biol. 6:745-750.
48. Morra, D. S., S. H. Lawler, B. P. Eliceiri, and G. L. Eliceiri. 1986. Inhibition of small nuclear RNA synthesis by ultraviolet radiation. J. Biol. Chem. 261:3142-3146.
49. Murphy, S., J. B. Yoon, T. Gerster, and R. G. Roeder. 1992. Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes. Mol. Cell. Biol. 12:3247-3261.
50. Qian, H., T. Wang, L. Naumovski, C. D. Lopez, and R. K. Brachmann. 2002. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene 21:7901-7911.
51. Sadowski, C. L., R. W. Henry, R. Kobayashi, and N. Hernandez. 1996. The SNAP45 subunit of the small nuclear RNA (snRNA) activating protein complex is required for RNA polymerase II and III snRNA gene transcription and interacts with the TATA box binding protein. Proc. Natl. Acad. Sci. USA 93:4289-4293.
52. Sadowski, C. L., R. W. Henry, S. M. Lobo, and N. Hernandez. 1993. Targeting TBP to a non-TATA box cis-regulatory element: a TBP-containing complex activates transcription from snRNA promoters through the PSE. Genes Dev. 7:1535-1548.
53. Sakaguchi, K., J. E. Herrera, S. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Andersen, and E. Appella. 1998. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:2831-2841.
54. Schaub, M., E. Myslinski, C. Schuster, A. Krol, and P. Carbon. 1997. Staf, a promiscuous activator for enhanced transcription by RNA polymerases II and III. EMBO J. 16:173-181.
55. Schramm, L., P. S. Pendergrast, Y. Sun, and N. Hernandez. 2000. Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters. Genes Dev. 14:2650-2663.
56. Selby, C. P., and A. Sancar. 1997. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc. Natl. Acad. Sci. USA 94:11205-11209.
57. Stein, T., D. Crighton, J. M. Boyle, J. M. Varley, and R. J. White. 2002. RNA polymerase III transcription can be derepressed by oncogenes or mutations that compromise p53 function in tumours and Li-Fraumeni syndrome. Oncogene 21:2961-2970.
58. Stein, T., D. Crighton, L. J. Warnock, J. Milner, and R. J. White. 2002. Several regions of p53 are involved in repression of RNA polymerase III transcription. Oncogene 21:5540-5547.
59. Tantin, D., A. Kansal, and M. Carey. 1997. Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes. Mol. Cell. Biol. 17:6803-6814.
60. Teichmann, M., Z. Wang, and R. G. Roeder. 2000. A stable complex of a novel transcription factor IIB-related factor, human TFIIIB50, and associated proteins mediate selective transcription by RNA polymerase III of genes with upstream promoter elements. Proc. Natl. Acad. Sci. USA 97:14200-14205.
61. Truant, R., H. Xiao, C. J. Ingles, and J. Greenblatt. 1993. Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. J. Biol. Chem. 268:2284-2287.
62. Van Den Boom, V., E. Citterio, D. Hoogstraten, A. Zotter, J. M. Egly, W. A. Van Cappellen, J. H. Hoeijmakers, A. B. Houtsmuller, and W. Vermeulen. 2004. DNA damage stabilizes interaction of CSB with the transcription elongation machinery. J. Cell Biol. 166:27-36.
63. van Gool, A. J., E. Citterio, S. Rademakers, R. van Os, W. Vermeulen, A. Constantinou, J. M. Egly, D. Bootsma, and J. H. Hoeijmakers. 1997. The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in an RNA polymerase II-containing complex. EMBO J. 16:5955-5965.
64. Vogelstein, B., D. Lane, and A. J. Levine. 2000. Surfing the p53 network. Nature 408:307-310.
65. Vousden, K. H. 2000. p53: death star. Cell 103:691-694.
66. Vousden, K. H., and X. Lu. 2002. Live or let die: the cell's response to p53. Nat. Rev. Cancer. 2:594-604.
67. Wang, X. W., H. Yeh, L. Schaeffer, R. Roy, V. Moncollin, J. M. Egly, Z. Wang, E. C. Freidberg, M. K. Evans, B. G. Taffe, et al. 1995. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 10:188-195.
68. Weinberg, R., and S. Penman. 1969. Metabolism of small molecular weight monodisperse nuclear RNA. Biochim. Biophys. Acta 190:10-29.
69. Wong, M. W., R. W. Henry, B. Ma, R. Kobayashi, N. Klages, P. Matthias, M. Strubin, and N. Hernandez. 1998. The large subunit of basal transcription factor SNAPc is a Myb domain protein that interacts with Oct-1. Mol. Cell. Biol. 18:368-377.
70. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J. L. Regier, S. J. Triezenberg, D. Reinberg, O. Flores, C. J. Ingles, et al. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14:7013-7024.
71. Yu, A., H. Y. Fan, D. Liao, A. D. Bailey, and A. M. Weiner. 2000. Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2, and SS genes. Mol. Cell 5:801-810.
72. Zhai, W., and L. Comai. 2000. Repression of RNA polymerase I transcription by the tumor suppressor p53. Mol. Cell. Biol. 20:5930-5938.